WO2015121698A1 - Deodorising preparation produced from natural ingredients and the process by which it is produced - Google Patents
Deodorising preparation produced from natural ingredients and the process by which it is produced Download PDFInfo
- Publication number
- WO2015121698A1 WO2015121698A1 PCT/HU2015/000017 HU2015000017W WO2015121698A1 WO 2015121698 A1 WO2015121698 A1 WO 2015121698A1 HU 2015000017 W HU2015000017 W HU 2015000017W WO 2015121698 A1 WO2015121698 A1 WO 2015121698A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- edible
- degrees
- natural
- coconut oil
- virgin
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 239000004615 ingredient Substances 0.000 title claims abstract description 22
- 238000000034 method Methods 0.000 title claims abstract description 15
- 230000008569 process Effects 0.000 title claims abstract description 12
- 239000003240 coconut oil Substances 0.000 claims abstract description 51
- 235000019864 coconut oil Nutrition 0.000 claims abstract description 51
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims abstract description 22
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000007788 liquid Substances 0.000 claims abstract description 12
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims abstract description 11
- 235000017557 sodium bicarbonate Nutrition 0.000 claims abstract description 11
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 10
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 10
- 230000000843 anti-fungal effect Effects 0.000 claims abstract description 9
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 8
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000011709 vitamin E Substances 0.000 claims abstract description 8
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 8
- 229940046009 vitamin E Drugs 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims description 19
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 16
- 239000005639 Lauric acid Substances 0.000 claims description 8
- 230000002829 reductive effect Effects 0.000 claims description 7
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 4
- 239000005445 natural material Substances 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 244000178870 Lavandula angustifolia Species 0.000 claims description 3
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 3
- 235000018219 lavender Nutrition 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 2
- 235000009024 Ceanothus sanguineus Nutrition 0.000 claims 1
- 240000003553 Leptospermum scoparium Species 0.000 claims 1
- 235000015459 Lycium barbarum Nutrition 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 239000001102 lavandula vera Substances 0.000 claims 1
- 239000000341 volatile oil Substances 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 description 16
- 210000003491 skin Anatomy 0.000 description 15
- 239000000126 substance Substances 0.000 description 15
- 239000003921 oil Substances 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 11
- 239000000243 solution Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 4
- 229940121375 antifungal agent Drugs 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 4
- 230000000254 damaging effect Effects 0.000 description 4
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 235000013162 Cocos nucifera Nutrition 0.000 description 3
- 244000060011 Cocos nucifera Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000001166 anti-perspirative effect Effects 0.000 description 3
- 239000003213 antiperspirant Substances 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 208000017520 skin disease Diseases 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 208000032170 Congenital Abnormalities Diseases 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 206010040904 Skin odour abnormal Diseases 0.000 description 2
- 244000028419 Styrax benzoin Species 0.000 description 2
- 235000000126 Styrax benzoin Nutrition 0.000 description 2
- 235000008411 Sumatra benzointree Nutrition 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 2
- 241001135917 Vitellaria paradoxa Species 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229960002130 benzoin Drugs 0.000 description 2
- 230000007698 birth defect Effects 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 231100000315 carcinogenic Toxicity 0.000 description 2
- 229940110456 cocoa butter Drugs 0.000 description 2
- 235000019868 cocoa butter Nutrition 0.000 description 2
- 239000002781 deodorant agent Substances 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000019382 gum benzoic Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 210000004251 human milk Anatomy 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000002766 immunoenhancing effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 239000010677 tea tree oil Substances 0.000 description 2
- 229940098465 tincture Drugs 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 239000010463 virgin olive oil Substances 0.000 description 2
- YVHVGFSDGHMIIG-UHFFFAOYSA-N 2-(2-tert-butylsulfonylethynylsulfonyl)-2-methylpropane Chemical compound CC(C)(C)S(=O)(=O)C#CS(=O)(=O)C(C)(C)C YVHVGFSDGHMIIG-UHFFFAOYSA-N 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 208000009043 Chemical Burns Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 208000012239 Developmental disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 235000021478 household food Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- -1 keytones Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000004768 organ dysfunction Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000005498 phthalate group Chemical class 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
Definitions
- the present invention pertains to a deodorising preparation produced from natural ingredients and the process by which it is produced which consists overwhelmingly of coconut oil and its exclusively natural derivatives produced by the treatment thereof, along with minute amounts of sodium bicarbonate, edible emulsifier, and vitamin E, with the possible addition of a scented material of natural origin such as adds to the useful value of the product.
- the invention is recommended for any user group, but, due to the natural components that render it basically edible, could be used by those who are sensitive to conventional industrially produced cosmetics, those who suffer from skin diseases, and even children.
- the specification provides a ratio of ingredients expressed in percent mass and volumetric quantities (7-17% beeswax, 21-29%) cocoa butter, 21-29% virgin coconut oil, 21-29% shea butter, 11.5-21.5% virgin olive oil, 0.1-20 ml lavender oil, 0.1-20 ml tincture of benzoin), and on this basis, offers several specific recipes.
- the beneficial effect of the preparation as used for various skin ailments e.g. eczema, chemical burns
- the preparation itself differs significantly from the one presented herein in terms of both ingredients and sphere of use. For one thing, it can be seen on the basis of the percent composition that coconut oil is not the overwhelmingly primary ingredient as it is in our solution. Furthermore, the ointment contains neither liquid (fractionated) coconut oil, nor sodium bicarbonate. The objective of the invention is not to use and to improve upon the beneficial properties of coconut oil for cosmetic purposes, but to produce an ointment from several components suitable for the treatment of skin diseases.
- Patent specification US 20080199544 describes a use of liquid (fractionated) coconut oil for dermatological purposes.
- the invention is actually the discovery of this use: that said oil is effective in preventing and treating skin disorders (including dry skin, eczema, non-atopic dermatitis).
- skin disorders including dry skin, eczema, non-atopic dermatitis.
- the specification does not mention other additives, nor does it note any cosmetic use or related functional requirements.
- propylene glycol solvent and humectant may damage the central nervous system, liver, and heart
- Butylated hydroxytoluene preservative may cause developmental disorders, allergies, and/or biochemical and cellular changes; may disturb endocrine function
- a cosmetic product can only represent high quality if it performs its designated function with only minimal health risks, the best guarantee for which is to build on traditionally applied, natural substances with well-known effects, chemically treated only to the extent that is absolutely necessary.
- organic products created with this philosophy in mind, on the market for some time now.
- coconut oil as our base ingredient, as when used appropriately, it meets the largest number of the requirements listed above:
- coconut oil is produced from coconuts.
- a ripe coconut is a hard-shelled fruit covered in tough, fibrous threads that weighs 1-2 kg and has a diameter of about 25-30 cm. Every part of the coconut can be used for something, whether for industrial, dietary, or cosmetic purposes.
- coconut oil When freshly pressed, coconut oil is white and has a characteristically pleasant scent. It is rich in the roughage, vitamins, and minerals required by the human body.
- coconut oil can take any one of four forms: a) Cold-pressed coconut oil
- a mechanically produced oil that has not undergone the RDB process has not been refined, bleached, and deodorised), nor been hydrogenated and that congeals at temperatures below 24°C.
- the percent content of long-chain lauric acid is typically above 47% in extra virgin and cold-pressed coconut oil, but is reduced to around 1 1% in the fractionated variety.
- concentration of lauric acid in mother's milk falls between just 6% and 10%, the subject of this patent will be able protect - and even enhance - the immune system to a very substantial degree.
- coconut oil that has undergone RBD processing has been refined, bleached, and deodorised.
- Refined coconut oil is transparent or yellowish in colour, has a neutral taste and odour, congeals at temperatures below 24°C, and is excellent for cooking and frying. In the course of refinement, however, it loses its valuable vitamin and amino acid content and is therefore of less value to the human body. Because it is hydrogenated, it remains stable even at higher temperatures and food cooked in it keeps longer; however, when used by the human body, small amounts of damaging trans fats are generated. d) Fractionated coconut oil
- Fractionated coconut oil is colourless liquid with a neutral taste and odour that congeals at 3°C.
- the oil has antifungal, antibacterial, and antiseptic properties and as a result, serves as a treatment against both inflammation and dry skin.
- the percent ranges for various components of coconut oil were determined by experiment with the following circumstances taken into account: a) After purchase, cosmetic products are generally kept in the bathroom, which, depending on the personal habits of the consumer, is heated either continuously, or only when in use. Since bathrooms are connected in some way to the other rooms of the house, it can be reasonably assumed that the temperature will not fall below a certain level. Our first point of reference was taken to be 8 degrees, as the temperature in the vast majority of households will never fall below this level. In order to ensure that our invention should congeal at 8 degrees, the coconut oil mixture must be 59 m/m % virgin and 39 m/m % fractionated oil.
- baking soda sodium bicarbonate
- Most anti-perspirant cosmetics already contain a significant amount of baking soda (typically 20-30%) for both the reasons state above, and because it represents an expedient and - not unimportantly - inexpensive solution to the problem of dermatologically neutralising the organic acids they contain. It is also important to remember, however, that the excessive use of this material can dry the skin and cause irritation.
- our invention is prepared using only the most necessary amount of sodium bicarbonate, and this was certainly possible, given that the pH of coconut oil does not justify the addition of an excessive amount of alkaline material.
- fatty acids, hydrocarbons, keytones, aldehydes, epoxides, and alcohols are produced, which give the initial substances/mixtures a sharp taste and unpleasant odour.
- antioxidants are added to oils and fats. Since for our invention, we require that the product be edible, of various antioxidant groups in general use, we chose that of E vitamins, which are most natural for the human body.
- the product is 100% natural in origin, its general use in the grocery industry serving as a guarantee of it edibility.
- the subject matter of this invention is a deodorising preparation produced from natural ingredients that consists of 100% natural substances, has anti -bacterial and anti-fungal properties, is dermatologically pH-neutral, and contains coconut oil.
- the preparation is characterised in that it is liquid above a minimum temperature of 8 degrees C, but preferably above 12 degrees C, is edible, and consists of at least 97 m/m% coconut oil, of which 17-59 mm/m% is fractionated and 39-80 m/m% is virgin coconut oil; 1-5 m/m% edible emulsifier; 0.5-1.5 m/m% edible vitamin E; 0.05-0.15 m/m% refined, edible sodium bicarbonate; and 0.05-0.15 m/m% optionally added, natural, edible scent.
- the lauric acid content is preferably 25-40 m/m%.
- the edible vitamin E is preferably Tocobiol.
- the edible emulsifier is preferably Dermofeel Viscolid.
- the edible, natural scent is lavender and/or tea tree oil.
- composition of the preparation according to this invention is described below via two examples, to which the scope of patent protection shall not be limited: 1. Composition of product for sale on the continent:
- Tocobiol 0.097 m/m%
- Tocobiol 0.097 m/m%
- the subject matter of this invention additionally extends to the process by which the deodorising preparation of natural ingredients is produced, which is conducted by separately heating quantities of virgin and fractionated coconut oil appropriate to pre-defined proportions to 65-70 degrees C.
- the virgin and fractionated coconut oils are mixed together and stirred for 4 minutes until it is determined that the mixture is homogenous enough.
- the natural emulsifier is added, preferably Dermofeel Viscolid, then, when this is completely dissolved, when the mixture is in the range of 25-30 degrees C, the natural vitamin E is added, then the refined, edible sodium bicarbonate, while using indirect cooling, the temperature is reduced to 18 degrees C. This is preferably done by holding the vessel is continuously held in water of 15-18 degrees C.
- the scent is mixed in, then the mixture cooled to 11 degrees C, at which temperature it is held for one hour. Finally, the mixture is returned to room temperature (20-25 degrees C) and left there until it regains its liquid form.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention pertains to a deodorising preparation produced from 100% natural ingredients, bearing anti-bacterial and anti-fungal, dermatologically pH-neutral properties, characterised in that it is liquid above a minimum temperature of 8 degrees C, but preferably above 12 degrees C, edible, and consists of at least 97 m/m% coconut oil, of which 17-59 mm/m% is fractionated and 39-80 m/m% is virgin coconut oil; 1-5 m/m% edible emulsifier; 0.5-1.5 m/m% edible vitamin E; 0.05-0.15 m/m% refined, edible sodium bicarbonate; and 0.05-0.15 m/m% optionally added, natural, edible scent. The subject matter of this invention additionally extends to the process by which the deodorising preparation of natural ingredients is produced
Description
DEODORISING PREPARATION PRODUCED FROM NATURAL INGREDIENTS AND THE PROCESS BY WHICH IT IS PRODUCED
The present invention pertains to a deodorising preparation produced from natural ingredients and the process by which it is produced which consists overwhelmingly of coconut oil and its exclusively natural derivatives produced by the treatment thereof, along with minute amounts of sodium bicarbonate, edible emulsifier, and vitamin E, with the possible addition of a scented material of natural origin such as adds to the useful value of the product.
The invention is recommended for any user group, but, due to the natural components that render it basically edible, could be used by those who are sensitive to conventional industrially produced cosmetics, those who suffer from skin diseases, and even children.
Preparations containing coconut oil have been on the market for a long time. Given the high lauric acid content of the oil, these products are specially recommended and used for not only cosmetic, but also expressly dermatological purposes. In the discussion to follow, we introduce the two solutions representing prior art that fall closest to the topic of this invention.
Patent specification US20060269507 discusses an ointment consisting of beeswax, cocoa butter, virgin coconut oil, shea oil, virgin olive oil, lavender oil, and tincture of benzoin. The specification provides a ratio of ingredients expressed in percent mass and volumetric quantities (7-17% beeswax, 21-29%) cocoa butter, 21-29% virgin coconut oil, 21-29% shea butter, 11.5-21.5% virgin olive oil, 0.1-20 ml lavender oil, 0.1-20 ml tincture of benzoin), and on this basis, offers several specific recipes. As regards the topic of use, the beneficial effect of the preparation as used for various skin ailments (e.g. eczema, chemical burns) is supported by means of examples.
The preparation itself differs significantly from the one presented herein in terms of both ingredients and sphere of use. For one thing, it can be seen on the basis of the percent composition that coconut oil is not the overwhelmingly primary ingredient as it is in our solution. Furthermore, the ointment contains neither liquid (fractionated) coconut oil, nor sodium bicarbonate. The objective of the invention is not to use and to improve upon the beneficial properties of coconut oil for cosmetic purposes, but to produce an ointment from several components suitable for the treatment of skin diseases.
Patent specification US 20080199544 describes a use of liquid (fractionated) coconut oil for dermatological purposes. The invention is actually the discovery of this use: that said oil is effective in preventing and treating skin disorders (including dry skin, eczema, non-atopic dermatitis). The specification does not mention other additives, nor does it note any cosmetic use or related functional requirements.
As regards our examination of the above and other solutions not mentioned in this description that are only slightly similar to this invention, it may be established that no cosmetic preparation featuring a mix overwhelmingly composed of fractionated and virgin coconut oil that contains only natural ingredients is currently known or patented, nor did any of the inventions we examined target the properties and attributes we have as objectives.
The inventions that represent current prior art, along with those that typify the cosmetics industry's current offerings for the problems of perspiration and unpleasant body odour are all generally characterised in that they operate with ingredients that carry serious health risks. Of these, the most significant are - but are not limited to - the following:
Ingredient Use, demonstrated side effects / risks
aluminium anti-perspirant; carcinogenic
parabens Antifungal and antibacterial, used as preservatives;
carcinogenic, upsets female hormonal balance and may therefore lead to organ dysfunction and birth defects
propylene glycol solvent and humectant; may damage the central nervous system, liver, and heart
phthalates Can disturb hormonal balance, decrease testosterone levels, cause birth defects, European Union regulations restrict their use
triclosan Antibacterial and antifungal organic substance; long-term use can cause cancer and may negatively affect thyroid function
Butylated hydroxytoluene preservative; may cause developmental disorders, allergies, and/or biochemical and cellular changes; may disturb endocrine function
Other chemical substances can also cause users or those in the user's environment unpleasant dermatological or respiratory reactions, such as various forms of skin irritation, sneezing, allergic symptoms.
But it is not only the adverse effects described above that render the task of inhibiting perspiration and disinfecting the skin via the artificial chemical substances used by the cosmetics industry problematic. Where such a method is used, toxins that the body is attempting to get rid of are forced into the lymphatic glands, which itself can cause serious conditions, from simple inflammation to tumorous diseases. The risk is lower with men because most of them apply anti-perspirant deodorants to the hair under their arms, thus creating a smaller blockage against perspiration than that experienced by women who shave their armpits.
The body needs to rid itself of toxic substances through mechanisms such as perspiration. When a body sweats, it releases not only moisture, but also various other secretions that, upon reaching the surface of the body, serve as food for the bacteria that live there. It is during the process by which these bacteria break down sweat that the compounds largely responsible for unpleasant body odours are created.
With this invention, our objective was to create a cosmetic substance - specifically, a deodorant preparation - that has all of the following properties:
- absorbs perspiration,
- kills bacteria and fungi,
- hydrates the skin,
does not cause irritation,
- is pH-neutral to the skin,
- is composed only of natural substances,
- is produced without the application of chemical processes,
- because of its natural ingredients, is technically edible,
- preserves its quality for a relatively long period of time,
gives its user a natural scent,
remains a liquid both at room temperature, and within as wide a range of temperatures close to room temperature as possible.
Given the above problems and factual information, we came to realise that the solution according to our invention could not rely primarily on stopping perspiration as a method, but that we must meet our stated objectives by avoiding the above-described cosmetic industry solutions, selecting a natural method and ingredients, and combining them in an effective manner.
In our view, a cosmetic product can only represent high quality if it performs its designated function with only minimal health risks, the best guarantee for which is to build on traditionally applied, natural substances with well-known effects, chemically treated only to the extent that is absolutely necessary.
At the same time, it must be noted that there have been exclusively organic products, created with this philosophy in mind, on the market for some time now. Most, however, including those described in the section above on prior art, include a large number of ingredients, which makes them difficult and expensive to manufacture, and in less fortunate cases, achieve the targeted effect only in reduced measure due to the "dilution" of their active ingredients.
We have furthermore recognised that we can meet our objectives best by using only one base substance, originating from a natural source, that has not been modified via industrial processes; thus, our invention builds overwhelmingly on this one substance and its various forms, and as regards active ingredients, aims to achieve the highest possible percent content of this one substance, once all circumstances have been taken into account.
Thus, for this invention, we have selected coconut oil as our base ingredient, as when used appropriately, it meets the largest number of the requirements listed above:
Coconut oil is produced from coconuts. A ripe coconut is a hard-shelled fruit covered in tough, fibrous threads that weighs 1-2 kg and has a diameter of about 25-30 cm. Every part of the coconut can be used for something, whether for industrial, dietary, or cosmetic purposes. When freshly pressed, coconut oil is white and has a characteristically pleasant scent. It is rich in the roughage, vitamins, and minerals required by the human body.
In practice coconut oil can take any one of four forms: a) Cold-pressed coconut oil
A clean, transparent liquid which, because of the lack of heat treatment, displays all the positive properties and contains all the beneficial components for which the oil is known. b) Virgin coconut oil
A mechanically produced oil that has not undergone the RDB process (has not been refined, bleached, and deodorised), nor been hydrogenated and that congeals at temperatures below 24°C. The percent content of long-chain lauric acid, the substance that is largely responsible for the oil's antibacterial, andtifungal, and immunoenhancing properties, is typically above 47% in extra virgin and cold-pressed coconut oil, but is reduced to around 1 1% in the fractionated variety. As the concentration of lauric acid in mother's milk, a natural source for
humans, falls between just 6% and 10%, the subject of this patent will be able protect - and even enhance - the immune system to a very substantial degree. c) Refined coconut oil
Coconut oil that has undergone RBD processing (has been refined, bleached, and deodorised). Refined coconut oil is transparent or yellowish in colour, has a neutral taste and odour, congeals at temperatures below 24°C, and is excellent for cooking and frying. In the course of refinement, however, it loses its valuable vitamin and amino acid content and is therefore of less value to the human body. Because it is hydrogenated, it remains stable even at higher temperatures and food cooked in it keeps longer; however, when used by the human body, small amounts of damaging trans fats are generated. d) Fractionated coconut oil
Oil extracted through fractional vacuum distillation, consisting largely of triglycerides with a reduced proportion of long-chain molecules. Fractionated coconut oil is colourless liquid with a neutral taste and odour that congeals at 3°C.
In the section to follow, we discuss the beneficial properties of coconut oil for which it has been selected as the principal ingredient of our invention:
C) Anti-bacterial and anti-fungal properties, dermatologically pH-neutral
The dermatological benefits of cold-pressed coconut oil have been known in Southeast Asia and the islands of the Pacific Ocean for millennia:
- The oil has antifungal, antibacterial, and antiseptic properties and as a result, serves as a treatment against both inflammation and dry skin.
- It is rich in polyphenols and therefore prevents the generation of free radicals and slows aging of the skin
- It hydrates the skin and increases its resilience
- It softens and sooths the skin, while providing nutrients to the epidermis
- It helps the skin maintain its natural pH
- It helps reduce the damaging effects of sunlight on the skin
The properties of virgin coconut oil are fundamentally identical to those of cold-pressed oil, while all other forms exhibit the above properties to reduced degrees, depending on exact chemical composition. The percent content of long-chain lauric acid, the substance that is largely responsible for the oil's antibacterial, antifungal, and immunoenhancing properties, is typically above 47% in extra virgin and cold-pressed coconut oil, but is reduced to around 11% in the fractionated variety. As the concentration of lauric acid in mother's milk, a natural source for humans, falls between just 6% and 10%, the subject of this patent will be able protect - and even enhance - the immune system to a very substantial degree.
We have also recognised that as the high lauric acid content raises the point where extra virgin and cold-pressed coconut oils congeal to around 24 degrees C, it is unsuited to cosmetic purposes unless an organic solvent or - where this is not available - a water- containing liquid and an emulsifier are added. As we did not wish to compromise with respect to our above-stated objectives, we sought a solution where the product remains in a liquid state for the largest possible domain of temperatures, as correspond with its field of use, by mixing coconut oil derivatives in the appropriate proportions.
In stating our claims below, the percent ranges for various components of coconut oil were determined by experiment with the following circumstances taken into account: a) After purchase, cosmetic products are generally kept in the bathroom, which, depending on the personal habits of the consumer, is heated either continuously, or only when in use. Since bathrooms are connected in some way to the other rooms of the house, it can be reasonably assumed that the temperature will not fall below a certain level. Our first point of reference was taken to be 8 degrees, as the temperature in the vast majority of households will never fall below this level. In order to ensure that our invention should congeal at 8 degrees, the coconut oil mixture must be 59 m/m % virgin and 39 m/m % fractionated oil. b) As we consider it conceivable that a product corresponding to our invention might also be distributed to places further south of Hungary and closer to the equator, where the levels of cold typical of the European continent do not arise even in winter, our second reference point was set at 18 degrees. In this case, the mixture should be made from 80 m/m % virgin and 17 m m % fractionated coconut oil.
In defining the composition of the coconut oils used in producing this invention, we departed from international test results and calculations conducted in the course of our own experiments. For fractionated and virgin coconut oils mixed in the appropriate proportions, individual saturated fatty acid concentrations vary according to the following table:
According to folk wisdom, household baking soda (sodium bicarbonate) can be rubbed under the arms as an easy, inexpensive way to prevent perspiration. The belief does, in fact, have scientific merit, as baking soda is highly absorbent and in solution is alkaline, so that it exerts
a destructive effect on fungi and bacteria that live on the skin and are adapted to its acidic pH. Most anti-perspirant cosmetics already contain a significant amount of baking soda (typically 20-30%) for both the reasons state above, and because it represents an expedient and - not unimportantly - inexpensive solution to the problem of dermatologically neutralising the organic acids they contain. It is also important to remember, however, that the excessive use of this material can dry the skin and cause irritation. In order to avoid undesirable side- effects, our invention is prepared using only the most necessary amount of sodium bicarbonate, and this was certainly possible, given that the pH of coconut oil does not justify the addition of an excessive amount of alkaline material.
As regards the rest of the components of the preparation, scientific research has shown no probability of skin irritation as a side effect.
Another indicator of the naturalness of this invention is that, while we intend it primarily for cosmetic use, we have formulated it to be edible, as well. In fact, what the digestive system, which is especially sensitive to damaging chemical substances, can process, cannot possibly be damaging to the skin and epidermis, which are defined as the body's first line of defence and are resistant to much harsher chemical and biological hazards. Since coconut oil is - based on millennia of experience - perfectly edible, while baking soda is used primarily in household food preparation and as a home remedy for heartburn, all that was left was to select an appropriate emulsifier to be used in combining the two. A further objective was to thicken and gelatinise the product (to aid in absorption) without changing the point at which it congeals. Thus, we selected Dermofeel Viscolid, as it was found to be the only substance on the market that has been irrefutably demonstrated to be both edible and free of side effects.
Both oils and fats - with particular reference to triglycerides with their unsaturated fatty acids - grow rancid when exposed to oxygen in the air. In the process, fatty acids, hydrocarbons, keytones, aldehydes, epoxides, and alcohols are produced, which give the initial substances/mixtures a sharp taste and unpleasant odour. To avoid this problem and to increase shelf life, antioxidants are added to oils and fats. Since for our invention, we require that the product be edible, of various antioxidant groups in general use, we chose that of E vitamins, which are most natural for the human body. Sixteen years of experience and research with Tocobiol, manufactured by BTSA, reveal it to be one of the best available
agents in preventing rancidity. The product is 100% natural in origin, its general use in the grocery industry serving as a guarantee of it edibility.
Our invention would fulfil all its target functions even if it contained only the ingredients listed above. However, for reasons of both the market and the product's use as a cosmetic, it was decided that scents might also be added in order to make it more attractive. In selecting these substances, again, care was taken that they should be both natural and edible. Thus, lavender and tea tree oils were chosen as solutions that would meet every requirement.
Thus, the subject matter of this invention is a deodorising preparation produced from natural ingredients that consists of 100% natural substances, has anti -bacterial and anti-fungal properties, is dermatologically pH-neutral, and contains coconut oil.
The preparation is characterised in that it is liquid above a minimum temperature of 8 degrees C, but preferably above 12 degrees C, is edible, and consists of at least 97 m/m% coconut oil, of which 17-59 mm/m% is fractionated and 39-80 m/m% is virgin coconut oil; 1-5 m/m% edible emulsifier; 0.5-1.5 m/m% edible vitamin E; 0.05-0.15 m/m% refined, edible sodium bicarbonate; and 0.05-0.15 m/m% optionally added, natural, edible scent.
In one preferred mode of carrying out the deodorising preparation according to this invention, the lauric acid content is preferably 25-40 m/m%.
In another preferred mode of carrying out the deodorising preparation according to this invention, the edible vitamin E is preferably Tocobiol.
In a third preferred mode of carrying out the deodorising preparation according to this invention, the edible emulsifier is preferably Dermofeel Viscolid.
In a fourth preferred mode of carrying out the deodorising preparation according to this invention, the edible, natural scent is lavender and/or tea tree oil.
The composition of the preparation according to this invention is described below via two examples, to which the scope of patent protection shall not be limited:
1. Composition of product for sale on the continent:
Fractionated coconut oil: 58.196 m/m %
Virgin coconut oil: 38.797 m/m %
Refined sodium bicarbonate: 0.970 m/m %
Dermofeel Viscolid: 1.940 m/m %
Tocobiol: 0.097 m/m%
2. Composition of product for sale in tropical areas:
Fractionated coconut oil: 16.993 m/m %
Virgin coconut oil: 80.000 m/m %
Refined sodium bicarbonate: 0.970 m/m %
Dermofeel Viscolid: 1.940 m/m %
Tocobiol: 0.097 m/m%
The subject matter of this invention additionally extends to the process by which the deodorising preparation of natural ingredients is produced, which is conducted by separately heating quantities of virgin and fractionated coconut oil appropriate to pre-defined proportions to 65-70 degrees C.
This is preferably conducted in two different vessels so that the vessels are each placed in another vessel containing water, which is heated directly.
When the above-mentioned temperature is reached, the virgin and fractionated coconut oils are mixed together and stirred for 4 minutes until it is determined that the mixture is homogenous enough. Then the natural emulsifier is added, preferably Dermofeel Viscolid, then, when this is completely dissolved, when the mixture is in the range of 25-30 degrees C, the natural vitamin E is added, then the refined, edible sodium bicarbonate, while using indirect cooling, the temperature is reduced to 18 degrees C. This is preferably done by holding the vessel is continuously held in water of 15-18 degrees C. When a range of 18-20 degrees C is reached, if desired, the scent is mixed in, then the mixture cooled to 11 degrees C, at which temperature it is held for one hour. Finally, the mixture is returned to room temperature (20-25 degrees C) and left there until it regains its liquid form.
In the course of this process, the blending of ingredients may be facilitated by gentle shaking.
On the basis of the above, it may be established that our invention has met the objectives set for it in every respect and that its advantages may be summarised as follows:
By contrast to other preparations based on natural materials, it offers significant antibacterial and antifungal properties
- It binds free radicals and thus slows the aging of the skin
- It does not inhibit, but rather merely absorbs perspiration, and thus does not obstruct the natural excretion of toxins by the skin
It has a natural scent that is not overpowering and thus can be used by those who are susceptible to allergies
- It does not irritate the skin
- Although it is made from coconut oil, the user need not fear that it will solidify and thus become unusable for even a short period of time
Claims
1. A deodorising preparation produced from natural ingredients that consists of 100% natural substances, has anti-bacterial and anti-fungal properties, is dermatologically pH-neutral, and contains coconut oil, characterised in that it is liquid above a minimum temperature of 8 degrees C, but preferably above 12 degrees C, is edible, and consists of at least 97 m/m% coconut oil, of which 17-59 mm/m% is fractionated and 39-80 m/m% is virgin coconut oil; 1- 5 m/m% edible emulsifier; 0.5-1.5 m/m% edible vitamin E; 0.05-0.15 m/m% refined, edible sodium bicarbonate; and 0.05-0.15 m/m% optionally added, natural, edible additives.
2. The preparation according to Claim 1, characterised in that the lauric acid concentration is 25-50 m/m%.
3. The preparation according to either Claim 1 or Claim 2, characterised in that the edible Vitamin E is preferably Tocobiol.
4. The preparation according to any of Claims 1 through 3, characterised in that the edible emulsifier is preferably Dermofeel Viscolid.
5. The preparation according to any of Claims 1 through 4, characterised in that the natural, edible additive is preferably lavender and/or tea tree scent or essential oil.
6. The process used for producing the deodorising preparation according to Claim 1, characterised in that quantities of virgin and fractionated coconut oil appropriate to predefined proportions are heated separately to 65-70 degrees C, preferably in two different vessels, so that the vessels are each placed in another, water-containing vessel that is heated directly, and when the above-mentioned temperature is reached, the virgin and fractionated coconut oils are mixed together and stirred for 4 minutes until it is determined that the mixture is sufficiently homogenous, after which the natural emulsifier is added and, when this is completely dissolved and the mixture is in the range of 25-30 degrees C, the natural vitamin E is added, followed by the refined, edible sodium bicarbonate, at which point the temperature of the mixture is reduced through indirect cooling to 18 degrees C by holding the vessel
continuously in water of 15-18 degrees C, and finally, when a range of 18-20 degrees C is reached, the scent is mixed in as prescribed by the recipe and the mixture cooled to 11 degrees C, where it is held for one hour until finally, the mixture returned to room temperature (20-25 degrees C) and left there to regain its liquid form.
7. The process according to Claim 6 characterised in that the blending of ingredients is facilitated by gentle shaking.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU1400082A HUP1400082A2 (en) | 2014-02-17 | 2014-02-17 | Deodorant composition produced by natural ingredients and process for its preparation |
HUP1400082 | 2014-02-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2015121698A1 true WO2015121698A1 (en) | 2015-08-20 |
WO2015121698A4 WO2015121698A4 (en) | 2015-11-19 |
Family
ID=89991403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/HU2015/000017 WO2015121698A1 (en) | 2014-02-17 | 2015-02-12 | Deodorising preparation produced from natural ingredients and the process by which it is produced |
Country Status (2)
Country | Link |
---|---|
HU (1) | HUP1400082A2 (en) |
WO (1) | WO2015121698A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020229209A1 (en) | 2019-05-16 | 2020-11-19 | Hulka S.R.L. | Deodorant composition |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113209229A (en) * | 2021-05-06 | 2021-08-06 | 湛江市依祈化妆品有限公司 | Privacy care preparation |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060269507A1 (en) | 2005-05-27 | 2006-11-30 | Susan Fuller | Topical ointment compostion and method for making the same |
US20080199544A1 (en) | 2007-02-16 | 2008-08-21 | Betty Bellman | Compositions and Methods for Alleviating Skin Disorders |
US20090208438A1 (en) * | 2008-02-20 | 2009-08-20 | Gorman Cynthia Delaney | Topical deodorant composition, and method of its manufacture and use |
WO2012064720A2 (en) * | 2010-11-08 | 2012-05-18 | Barone Salvatore J | Lipstick and other cosmetics and method of making |
-
2014
- 2014-02-17 HU HU1400082A patent/HUP1400082A2/en unknown
-
2015
- 2015-02-12 WO PCT/HU2015/000017 patent/WO2015121698A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060269507A1 (en) | 2005-05-27 | 2006-11-30 | Susan Fuller | Topical ointment compostion and method for making the same |
US20080199544A1 (en) | 2007-02-16 | 2008-08-21 | Betty Bellman | Compositions and Methods for Alleviating Skin Disorders |
US20090208438A1 (en) * | 2008-02-20 | 2009-08-20 | Gorman Cynthia Delaney | Topical deodorant composition, and method of its manufacture and use |
WO2012064720A2 (en) * | 2010-11-08 | 2012-05-18 | Barone Salvatore J | Lipstick and other cosmetics and method of making |
Non-Patent Citations (1)
Title |
---|
ANDREA MANITSAS: "Gettin' Pitty With It: The Best DIY Deodorant", 6 June 2011 (2011-06-06), XP002741573, Retrieved from the Internet <URL:http://www.organicauthority.com/health/best-diy-deodorant-homemade.html> [retrieved on 20150630] * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020229209A1 (en) | 2019-05-16 | 2020-11-19 | Hulka S.R.L. | Deodorant composition |
CN113924150A (en) * | 2019-05-16 | 2022-01-11 | 赫尔卡有限公司 | Deodorant composition |
Also Published As
Publication number | Publication date |
---|---|
HUP1400082A2 (en) | 2015-08-28 |
WO2015121698A4 (en) | 2015-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101128299B1 (en) | Natural soap by using of ripen and decocted oriental medicine and manufacturing method thereof | |
US20140248370A1 (en) | Enhancement Composition | |
Rekik et al. | Wound healing effect of Lawsonia inermis | |
WO2009008656A2 (en) | A soap composition for atopic dermatitis containing fermented extract of xanthium strumarium l. and preparation method thereof | |
CN105853260A (en) | Cream for treating diaper dermatitis and preparation method thereof | |
Jones | The Complete Guide to Creating Oils, Soaps, Creams, and Herbal Gels for Your Mind and Body: 101 Natural Body Care Recipes | |
CN105267119B (en) | It is a kind of to nourish moisturizing and injury repair lip gloss and preparation method thereof | |
CN105030613B (en) | A kind of natural plant essential oils foot lotion of antibacterial fatigue-relieving | |
CN104490635A (en) | Full-body massage oil and preparation method thereof | |
KR20210028959A (en) | Method of producing a skin moisturizing cosmetic composition for pets and cosmetic composition prepared thereby | |
Songkro et al. | Characterization of aromatherapy massage oils prepared from virgin coconut oil and some essential oils | |
WO2015121698A1 (en) | Deodorising preparation produced from natural ingredients and the process by which it is produced | |
CN104982553A (en) | Health-maintenance margarine | |
EP4153321A1 (en) | Topical compositions, process of large-scale manufacture, and method of use | |
Eze-Steven et al. | Evaluation of antioxidant potential of Monodora myristica (African Nutmeg) | |
CN109431922A (en) | Eatable assorted happy lip gloss of fruit of one kind and preparation method thereof | |
KR20160041302A (en) | Manufacturing method of cosmetic for acned skin containing hydrozol | |
KR101732977B1 (en) | Plant fat composition for making cosmetics | |
JP6651104B1 (en) | Method for producing external composition | |
CN102743506A (en) | Camellia japonica oil acne lotion and preparation method thereof | |
KR20160129401A (en) | Method for manufacturing natural soap and natural soap manufactured by the method | |
US9700500B1 (en) | Disposable wipes comprising of warming lubricants, vitamin E oil, and essential oils | |
RU2211026C1 (en) | Skin care cosmetic agent with wound-healing effect (balsam "aidas") | |
CN106038399B (en) | A kind of foot film and preparation method thereof of the anti-chap deodorization of anti-inflammatory | |
CN104893867A (en) | Honeysuckle flower handmade soap for bath |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15720775 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 31/01/2017) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 15720775 Country of ref document: EP Kind code of ref document: A1 |